CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 39 filers reported holding CUE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,540 | -58.2% | 7,626 | -33.7% | 0.00% | – |
Q2 2023 | $41,964 | -77.3% | 11,497 | -69.7% | 0.00% | – |
Q1 2022 | $185,000 | -59.7% | 37,943 | -6.5% | 0.00% | -100.0% |
Q4 2021 | $459,000 | -19.8% | 40,572 | +3.4% | 0.00% | 0.0% |
Q3 2021 | $572,000 | +19.7% | 39,229 | -4.5% | 0.00% | 0.0% |
Q2 2021 | $478,000 | -11.6% | 41,060 | -7.3% | 0.00% | 0.0% |
Q1 2021 | $541,000 | -2.3% | 44,311 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $554,000 | -15.4% | 44,311 | +1.8% | 0.00% | 0.0% |
Q3 2020 | $655,000 | -36.1% | 43,545 | +4.2% | 0.00% | -50.0% |
Q2 2020 | $1,025,000 | +133.5% | 41,809 | +35.3% | 0.00% | +100.0% |
Q1 2020 | $439,000 | -9.5% | 30,904 | +1.2% | 0.00% | 0.0% |
Q4 2019 | $485,000 | +88.0% | 30,549 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $258,000 | +2.0% | 30,549 | +8.4% | 0.00% | – |
Q2 2019 | $253,000 | +16.1% | 28,175 | 0.0% | 0.00% | – |
Q1 2019 | $218,000 | +71.7% | 28,175 | +4.1% | 0.00% | – |
Q4 2018 | $127,000 | -48.2% | 27,053 | 0.0% | 0.00% | – |
Q3 2018 | $245,000 | -23.7% | 27,053 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $321,000 | +68.1% | 27,053 | +99.3% | 0.00% | – |
Q1 2018 | $191,000 | – | 13,573 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |